- Home
- BIO vs PAC Comparison
BIO vs PAC Comparison
Compare BIO & PAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BIO
- PAC
- Stock Information
- Founded
- BIO 1952
- PAC 1998
- Country
- BIO United States
- PAC Mexico
- Employees
- BIO N/A
- PAC N/A
- Industry
- BIO Biotechnology: Laboratory Analytical Instruments
- PAC Aerospace
- Sector
- BIO Industrials
- PAC Consumer Discretionary
- Exchange
- BIO Nasdaq
- PAC Nasdaq
- Market Cap
- BIO 6.0B
- PAC 10.4B
- IPO Year
- BIO N/A
- PAC 2006
- Fundamental
- Price
- BIO $251.56
- PAC $233.25
- Analyst Decision
- BIO Strong Buy
- PAC Buy
- Analyst Count
- BIO 4
- PAC 6
- Target Price
- BIO $324.25
- PAC $207.50
- AVG Volume (30 Days)
- BIO 406.1K
- PAC 122.8K
- Earning Date
- BIO 07-31-2025
- PAC 07-22-2025
- Dividend Yield
- BIO N/A
- PAC 3.11%
- EPS Growth
- BIO N/A
- PAC N/A
- EPS
- BIO N/A
- PAC 0.86
- Revenue
- BIO $2,541,100,000.00
- PAC $1,435,598,195.00
- Revenue This Year
- BIO N/A
- PAC $57.91
- Revenue Next Year
- BIO $3.49
- PAC $8.28
- P/E Ratio
- BIO N/A
- PAC $27.23
- Revenue Growth
- BIO N/A
- PAC 14.67
- 52 Week Low
- BIO $211.43
- PAC $146.62
- 52 Week High
- BIO $387.99
- PAC $241.62
- Technical
- Relative Strength Index (RSI)
- BIO 65.86
- PAC 58.52
- Support Level
- BIO $237.42
- PAC $225.18
- Resistance Level
- BIO $254.82
- PAC $237.15
- Average True Range (ATR)
- BIO 7.14
- PAC 5.37
- MACD
- BIO 2.35
- PAC 0.36
- Stochastic Oscillator
- BIO 89.82
- PAC 84.13
About BIO Bio-Rad Laboratories Inc.
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.
About PAC Grupo Aeroportuario Del Pacifico S.A. B. de C.V. Grupo Aeroportuario Del Pacifico S.A. de C.V. (each representing 10 Series B shares)
Grupo Aeroportuario del Pacifico SAB de CV is engaged in the construction, development, and operation of airports in Mexico. The company's segment includes Guadalajara; Tijuana; Puerto Vallarta; San Jose del Cabo; Montego Bay; Hermosillo; Guanajuato and Other Airports. It generates maximum revenue from the Guadalajara segment.